Doximity (DOCS) Q1 2027 Earnings Call Transcript
Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.
How this was made
The 30-second read
Why it matters
Traders can update valuation assumptions using the raised FY 2027 revenue and adjusted EBITDA ranges, plus near-term Q2 revenue guidance. The call also highlights margin and cash flow tradeoffs from increased AI compute spending and timing of collections.
Market read
Raised FY 2027 guidance and strong AI engagement metrics are the main catalysts, while margin compression and lower FCF add risk to the earnings quality narrative.
What to watch
Enterprise AI security demand is tied to PHI prompt handling (about 30%), which could increase costs and slow adoption if clinician accuracy/liability concerns intensify.
Background
The article is a transcript-style summary of Doximity’s Fiscal 2027 first-quarter earnings call, including financial results, AI product adoption metrics, and updated guidance.
Ticker impact
Doximity raised full-year 2027 revenue guidance to $671M-$681M and adjusted EBITDA to $309M-$329M, citing AI search traction.
Near-term bias higher as traders price in the raised 2027 revenue and EBITDA ranges, tempered by weaker FCF and lower non-GAAP gross margin.
The article provides multiple new, decision-relevant datapoints: raised FY guidance, Q2 revenue guidance, margin and FCF changes, and specific AI monetization economics (10x revenue per search vs cost).
Market effects
Reinforces demand for HIPAA-compliant clinical AI and secure enterprise deployments, potentially supporting sentiment for healthcare AI platforms.
Primarily US healthcare IT and pharma/hospital customer spending sentiment.
Limited direct global read-through; mostly US provider and pharma budget dynamics.
Counterpoint
The guidance raise may be driven by timing and recognition of AI search revenue starting in Q3, while non-GAAP gross margin fell and FCF dropped 34% YoY, suggesting quality of earnings could be questioned.
Key entities
- companyDoximity
Digital platform for medical professionals; reported Q1 results and raised FY 2027 guidance tied to clinical AI and AI search adoption.
- personJeffrey Tangney
CEO who discussed AI safety performance, AI Scribe growth, and enterprise AI steering committee concerns.
- personMatthew Sonefeldt
CFO who provided guidance ranges and discussed the tough YoY comparison and margin/FCF drivers.
